查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462721

到 2030 年高流量氧气鼻管市场预测：按组件、销售管道、应用、最终用户和地区进行的全球分析

High-flow Nasal Cannula Market Forecasts to 2030 - Global Analysis By Component, Sales Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球高流量氧气鼻管市场规模为 77 亿美元，预计在预测期内将以 14% 的复合年增长率成长，到 2030 年达到 192.7 亿美元。

高流量氧气鼻管是一种呼吸治疗装置，可透过小鼻管以高流速输送加热、湿润的氧气。此疗法用于治疗急性呼吸衰竭患者，提供精确的氧合水平，同时提供舒适感并减少呼吸功。加热和加湿的气体混合物提高了患者的耐受性和活动能力，同时高流量确保气道开放，减少气道阻力，并可能减少对有创机械通气的需求。

根据世界卫生组织 (WHO) 估计，全球有 2.35 亿人患有气喘。

呼吸道疾病盛行率增加

慢性阻塞性肺病(COPD)、气喘和急性呼吸窘迫症候群(ARDS) 等呼吸道疾病在全球呈现上升趋势。这些疾病通常需要有效的氧气疗法来缓解呼吸窘迫并改善患者的预后。高流量鼻插管对于呼吸系统疾病患者特别有益，因为与传统氧气疗法方法相比，它们提供更高流量的氧气。此外，它还提供恆定且可调节的氧气供应，确保充足的氧合併减少患者呼吸系统的压力。

高成本

HFNC 系统对于医疗保健提供者来说可能是一个经济挑战，因为与传统的氧气疗法相比，它们相对昂贵。购买 HFNC 系统（包括流量产生器和加热加湿器）所需的初始投资可能非常巨大。设备定期维护和校准的需要进一步增加了经济负担，从而限制了市场成长。

技术进步

HFNC 技术的不断创新和改进提高了其性能、安全性和患者舒适度，推动了采用和利用率的提高。流量产生器、加热加湿器和氧气鼻管的设计创新正在提高 HFNC 治疗的性能和舒适度。此外，製造商还推出了具有柔软、灵活、符合解剖学轮廓的氧气鼻管，可提高患者舒适度并减少皮肤刺激。插管设计的这些进步也有助于更好地输送氧气，并降低鼻部创伤的风险。

与替代呼吸辅助性治疗的竞争

高流量氧气鼻管（HFNC）市场面临来自替代呼吸辅助性治疗的竞争的限制。透过双水平阳压呼吸器(BiPAP) 和持续性阳压呼吸器(CPAP) 等装置提供的非侵入性通气可提供不同程度的压力支持，以帮助呼吸衰竭患者呼吸。此外，患有严重呼吸窘迫或急性呼吸衰竭的患者通常需要侵入性机械通气，包括人工呼吸器支持。

COVID-19 的影响

COVID-19 大流行增加了对治疗患有严重呼吸道症状的患者的呼吸辅助设备的需求，推动了高流量氧气鼻管(HFNC) 市场，特别是与 COVID-19 相关的呼吸困难产生了巨大影响。此外，HFNC 能够提供高流量氧气疗法，同时保持气道最佳水合作用并减少有创通气的需求，这使得 HFNC 对 COVID-19 患者特别是急性呼吸衰竭或急性呼吸窘迫症候群(ARDS) 患者非常有用。

预计氧气鼻管部分在预测期内将是最大的

据估计，氧气鼻管段所占份额最大。氧气鼻管由插入患者鼻孔的软管和连接到调节氧气流量的专用装置的管子组成。高流量与加热和加湿的氧气相结合，可保持气道的最佳水合作用，减少黏膜发炎并提高患者的舒适度。与传统方法相比，高流量氧气鼻管市场由于其在提供氧气疗法、改善患者治疗效果和提高舒适度方面的有效性而正在经历显着增长。

预计急性呼吸衰竭在预测期内的复合年增长率最高

预计急性呼吸衰竭细分市场在预测期内将出现良好成长。透过以精确调节的流量提供温暖、湿润的氧气，HFNC 可提高患者舒适度、减少气道阻力并减少呼吸功。这些因素对于 ARF 的治疗特别有益，因为患者经常会经历呼吸困难和不适。此外，HFNC 治疗可以避免在某些 ARF 病例中需要有创机械通气，并降低与插管及其併发症相关的风险。

比最大的地区

由于北美地区能够有效地为有呼吸问题的患者提供高流量氧气疗法，因此在预测期内占据了最大的市场占有率。该地区拥有先进的医疗基础设施和慢性呼吸道疾病的高盛行率，推动了对 HFNC 系统的需求。此外，该地区人口老化以及慢性阻塞性肺病(COPD) 和睡眠呼吸中止症等疾病的高发生率也进一步支持了 HFNC 疗法的采用。

复合年增长率最高的地区：

由于生活方式的改变，预计亚太地区在预测期内将出现盈利成长。污染水平的不断上升、烟草消费和人口老化导致慢性阻塞性肺病(COPD) 和呼吸道感染疾病等疾病的盛行率不断上升，因此需要有效的治疗方法，例如 HFNC 呼吸支持系统。此外，改善医疗基础设施、扩大医疗服务范围以及不断上涨的医疗成本进一步刺激了亚太地区对先进呼吸护理设备的需求。

提供免费客製化：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球高流量氧气鼻管市场：依组成部分

  • 加湿器
  • 氧气鼻管
  • 单加热管
  • 空气/氧气混合物
  • 其他组件

第六章全球高流量氧气鼻管市场：依销售管道

  • 代理销售
  • 直销

第七章全球高流量氧气鼻管市场：依应用分类

  • 急性呼吸衰竭
  • 睡眠呼吸中止症
  • 一氧化碳毒性
  • 急性呼吸衰竭
  • 支气管扩张
  • 慢性阻塞性肺病（COPD）
  • 其他用途

第八章全球高流量氧气鼻管市场：依最终用户分类

  • 断层合成
  • 门诊治疗中心
  • 医院
  • 长期照护中心
  • 其他最终用户

第九章全球高流量氧气鼻管市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Becton, Dickinson and Company
  • Fisher & Paykel Healthcare Corporation Ltd.
  • Flexicare Medical Ltd.
  • Great Group Medical Co., Ltd.
  • Hamilton Medical AG
  • MEK-ICS Co., Ltd.
  • Resmed Inc.
  • Salter Labs Inc.
  • Smiths Medical
  • Teijin Pharma Ltd.
  • Teleflex, Inc.
  • TNI Medical AG
  • Vapotherm, Inc.
Product Code: SMRC25772

According to Stratistics MRC, the Global High-flow Nasal Cannula Market is accounted for $7.7 billion in 2023 and is expected to reach $19.27 billion by 2030 growing at a CAGR of 14% during the forecast period. A high-flow nasal cannula is a respiratory therapy device that delivers heated and humidified oxygen at high flow rates through small nasal prongs. This therapy is used to treat patients with acute respiratory failure by providing precise oxygenation levels while offering comfort and reducing the work of breathing. The warmed and humidified gas mixture enhances patient tolerance and mobilization, while the high flow rates help to splint open airways, decrease airway resistance, and potentially reduce the need for invasive mechanical ventilation.

According to the World Health Organization It is estimated that 235 million people worldwide have asthma.

Market Dynamics:

Driver:

Rising prevalence of respiratory disorders

Respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory distress syndrome (ARDS) have been on the rise globally. These conditions often require effective oxygen therapy to alleviate respiratory distress and improve patient outcomes. High-flow nasal cannulas deliver a higher flow rate of oxygen compared to traditional oxygen therapy methods, making them particularly beneficial for patients with respiratory disorders. Moreover, they provide a constant and adjustable supply of oxygen, ensuring adequate oxygenation and reducing the workload on the patient's respiratory system.

Restraint:

High cost

HFNC systems can be relatively expensive compared to traditional oxygen therapy methods, which can pose financial challenges for healthcare providers. The initial investment required to purchase the HFNC system, including the flow generator and heated humidifier, can be substantial. The need for regular maintenance and calibration of the equipment further adds to the financial burden, which in turn limits market growth.

Opportunity:

Technological advancements

Ongoing innovations and improvements in HFNC technology have enhanced its performance, safety, and patient comfort, driving increased adoption and utilization. Innovations in flow generators, heated humidifiers, and nasal cannula design have enhanced the performance and comfort of HFNC therapy. Furthermore, manufacturers have introduced soft, flexible, and anatomically contoured nasal cannulas that enhance patient comfort and reduce skin irritation. These advancements in cannula design also contribute to better oxygen delivery and reduce the risk of nasal trauma.

Threat:

Competition from alternative respiratory support therapies

The high-flow nasal cannula (HFNC) market faces restraints due to competition from alternative respiratory support therapies. Non-invasive ventilation, delivered through devices such as bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) provides varying levels of pressure support to assist breathing in patients with respiratory failure. Furthermore, invasive mechanical ventilation, involving end tracheal intubation and mechanical ventilator support, is often required for patients with severe respiratory distress or acute respiratory failure.

Covid-19 Impact

The COVID-19 pandemic has significantly impacted the high-flow nasal cannula (HFNC) market by increasing the demand for respiratory support devices to treat patients with severe respiratory symptoms, particularly those suffering from COVID-19-related respiratory distress. Moreover, due to its ability to deliver high-flow oxygen therapy while maintaining optimal airway hydration and reducing the need for invasive ventilation, HFNC has become a preferred option for treating COVID-19 patients, especially those experiencing acute respiratory failure or acute respiratory distress syndrome (ARDS).

The nasal cannula segment is expected to be the largest during the forecast period

The nasal cannula segment is estimated to hold the largest share. The nasal cannula consists of soft prongs that are inserted into the patient's nostrils, along with tubing connected to a specialized device that regulates the flow of oxygen. The high flow rate, combined with the heated and humidified oxygen, helps maintain optimal airway hydration, reduces mucosal irritation, and improves patient comfort. The high-flow nasal cannula market has experienced significant growth due to its effectiveness in delivering oxygen therapy, improving patient outcomes, and enhancing comfort compared to traditional methods.

The acute respiratory failure segment is expected to have the highest CAGR during the forecast period

The acute respiratory failure segment is anticipated to have lucrative growth during the forecast period. By delivering a precisely regulated flow of warm and humidified oxygen, HFNCs improve patient comfort, reduce airway resistance, and decrease the work of breathing. These factors are particularly beneficial in the management of ARF, where patients often experience respiratory distress and discomfort. Furthermore, HFNC therapy can prevent the need for invasive mechanical ventilation in some ARF cases, thereby reducing the risks associated with intubation and its complications.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to due to its efficacy in delivering high-flow oxygen therapy to patients with respiratory issues. This region boasts advanced healthcare infrastructure and a high prevalence of chronic respiratory diseases, driving the demand for HFNC systems. Additionally, the region's aging population and the incidence of conditions like chronic obstructive pulmonary disease (COPD) and sleep apnea further fuel the adoption of HFNC therapy.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the lifestyle changes. Rising pollution levels, tobacco consumption, and an aging population contribute to the growing prevalence of conditions like chronic obstructive pulmonary disease (COPD) and respiratory infections, necessitating effective respiratory support systems such as HFNCs. Moreover, improving healthcare infrastructure, expanding access to healthcare services, and increasing healthcare expenditure further stimulate the demand for advanced respiratory care devices in APAC.

Key players in the market

Some of the key players in the High-flow Nasal Cannula Market include Becton, Dickinson and Company, Fisher & Paykel Healthcare Corporation Ltd., Flexicare Medical Ltd., Great Group Medical Co., Ltd., Hamilton Medical AG, MEK-ICS Co., Ltd., Resmed Inc., Salter Labs Inc., Smiths Medical, Teijin Pharma Ltd., Teleflex, Inc., TNI Medical AG and Vapotherm, Inc.

Key Developments:

In January 2024, BD (Becton, Dickinson and Company) and Techcyte announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and pre cancer using whole-slide imaging.

In November 2023, Teijin Limited announced that the company has entered into an exclusive license agreement with Ascendis Pharma A/S for the further development and commercialization of TransCon hGH, TransCon PTH, and TransCon CNP for endocrinology rare disease in Japan.

In March 2023, Becton Dickinson and the Agency for Science, Technology and Research have announced an extended research partnership that will focus on deep immune phenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated into positive healthcare outcomes.

Components Covered:

  • Air Humidifier
  • Nasal Cannula
  • Single Heated Tube
  • Air/Oxygen Blend
  • Other Components

Sales Channels Covered:

  • Distributor Sales
  • Direct Sales

Applications Covered:

  • Acute Respiratory Failure
  • Sleep Apnea
  • Carbon Monoxide Toxicity
  • Acute Respiratory Failure
  • Bronchiectasis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other Applications

End Users Covered:

  • Tomosynthesis
  • Ambulatory Care Centers
  • Hospitals
  • Long-term Care Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Flow Nasal Cannula Market, By Component

  • 5.1 Introduction
  • 5.2 Air Humidifier
  • 5.3 Nasal Cannula
  • 5.4 Single Heated Tube
  • 5.5 Air/Oxygen Blend
  • 5.6 Other Components

6 Global High Flow Nasal Cannula Market, By Sales Channel

  • 6.1 Introduction
  • 6.2 Distributor Sales
  • 6.3 Direct Sales

7 Global High Flow Nasal Cannula Market, By Application

  • 7.1 Introduction
  • 7.2 Acute Respiratory Failure
  • 7.3 Sleep Apnea
  • 7.4 Carbon Monoxide Toxicity
  • 7.5 Acute Respiratory Failure
  • 7.6 Bronchiectasis
  • 7.7 Chronic Obstructive Pulmonary Disease (COPD)
  • 7.8 Other Applications

8 Global High Flow Nasal Cannula Market, By End User

  • 8.1 Introduction
  • 8.2 Tomosynthesis
  • 8.3 Ambulatory Care Centers
  • 8.4 Hospitals
  • 8.5 Long-term Care Centers
  • 8.6 Other End Users

9 Global High Flow Nasal Cannula Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Becton, Dickinson and Company
  • 11.2 Fisher & Paykel Healthcare Corporation Ltd.
  • 11.3 Flexicare Medical Ltd.
  • 11.4 Great Group Medical Co., Ltd.
  • 11.5 Hamilton Medical AG
  • 11.6 MEK-ICS Co., Ltd.
  • 11.7 Resmed Inc.
  • 11.8 Salter Labs Inc.
  • 11.9 Smiths Medical
  • 11.10 Teijin Pharma Ltd.
  • 11.11 Teleflex, Inc.
  • 11.12 TNI Medical AG
  • 11.13 Vapotherm, Inc.

List of Tables

  • Table 1 Global High Flow Nasal Cannula Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 4 Global High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 5 Global High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 6 Global High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 7 Global High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 8 Global High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 9 Global High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 10 Global High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 11 Global High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 13 Global High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 14 Global High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 15 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 16 Global High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 17 Global High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 18 Global High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 19 Global High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 21 Global High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 22 Global High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 23 Global High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 24 Global High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 27 North America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 28 North America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 29 North America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 30 North America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 31 North America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 32 North America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 33 North America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 34 North America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 35 North America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 37 North America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 38 North America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 39 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 40 North America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 41 North America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 42 North America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 43 North America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 44 North America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 45 North America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 46 North America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 47 North America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 48 North America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 51 Europe High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 52 Europe High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 53 Europe High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 54 Europe High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 55 Europe High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 56 Europe High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 57 Europe High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 58 Europe High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 59 Europe High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 60 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 61 Europe High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 62 Europe High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 63 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 64 Europe High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 65 Europe High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 66 Europe High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 67 Europe High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 68 Europe High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 69 Europe High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 70 Europe High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 71 Europe High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 72 Europe High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 75 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 76 Asia Pacific High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 77 Asia Pacific High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 78 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 79 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 80 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 81 Asia Pacific High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 82 Asia Pacific High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 83 Asia Pacific High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 84 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 85 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 86 Asia Pacific High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 87 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 88 Asia Pacific High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 89 Asia Pacific High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 90 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 91 Asia Pacific High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 92 Asia Pacific High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 93 Asia Pacific High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 94 Asia Pacific High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 95 Asia Pacific High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 96 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 99 South America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 100 South America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 101 South America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 102 South America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 103 South America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 104 South America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 105 South America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 106 South America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 107 South America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 108 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 109 South America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 110 South America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 111 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 112 South America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 113 South America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 114 South America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 115 South America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 116 South America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 117 South America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 118 South America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 119 South America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 120 South America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 123 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 124 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 125 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 126 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 127 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 128 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 129 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 130 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 131 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 132 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 133 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 134 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 135 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 136 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 137 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 138 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 139 Middle East & Africa High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 140 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 141 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 142 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 143 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 144 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)